MENU
+Compare
SCPH
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$2.50
Change
+$0.16 (+6.87%)
Capitalization
125.71M

SCPH scPharmaceuticals Forecast, Technical & Fundamental Analysis

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs... Show more

SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SCPH with price predictions
Apr 01, 2025

SCPH's Stochastic Oscillator remains in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCPH advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

SCPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SCPH as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SCPH turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for SCPH crossed bearishly below the 50-day moving average on March 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SCPH entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.434) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.064) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SCPH is expected to report earnings to fall 8.57% to -31 cents per share on May 20

scPharmaceuticals SCPH Stock Earnings Reports
Q1'25
Est.
$-0.32
Q4'24
Beat
by $0.03
Q3'24
Missed
by $0.45
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.06
The last earnings report on March 19 showed earnings per share of -34 cents, beating the estimate of -37 cents. With 551.85K shares outstanding, the current market capitalization sits at 125.71M.
A.I. Advisor
published General Information

General Information

a provider of transformative pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
25 Mall Road
Phone
+1 617 517-0730
Employees
136
Web
https://www.scpharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WGROX81.440.28
+0.34%
Wasatch Core Growth
HADUX69.500.12
+0.17%
Horizon Equity Premium Income Advisor
TWEBX17.89N/A
N/A
Tweedy, Browne Value
BMSSX13.59N/A
N/A
MFS Blended Research Mid Cap Eq R2
MSBQX11.83N/A
N/A
Morgan Stanley American Resilience R6

SCPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with AVIR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-11.41%
AVIR - SCPH
40%
Loosely correlated
-4.68%
CDXS - SCPH
39%
Loosely correlated
-6.69%
XERS - SCPH
39%
Loosely correlated
-7.47%
BEAM - SCPH
38%
Loosely correlated
-9.70%
AURA - SCPH
38%
Loosely correlated
-3.24%
More